Clinical Trial Update: Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating clearance of minimal residual disease at the end of first-line treatment in patients with lymphoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Hodgkin Lymphoma

Snippet

Sponsor: Centre Henri Becquerel | Conditions: B-cell Lymphoma, Hodgkin Lymphoma | NA | Status: ACTIVE_NOT_RECRUITING